Maltais, Francois; Buhl, Roland; Koch, Andrea et al.
beta-Blockers in COPD A Cohort Study From the TONADO Research ProgramCHEST. Bd. 153. H. 6. 2018 S. 1315-1325
Kindler, Thomas
CHIPing out PPM1D-mutant hematopoiesisBLOOD. Bd. 132. H. 11. 2018 S. 1087-1088
Jurczak, Wojciech; Ramanathan, Sundra; Giri, Pratyush et al.
Comparison of two doses of intravenous temsirolimus in patients with relapsed/refractory mantle cell lymphomaLEUKEMIA & LYMPHOMA. Bd. 59. H. 3. 2018 S. 670-678
Volmer, Timm; Effenberger, Timo; Trautner, Christoph et al.
Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literatureEUROPEAN RESPIRATORY JOURNAL. Bd. 52. H. 4. 2018
Gaidzik, V. I.; Weber, D.; Paschka, P. et al.
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemiaLEUKEMIA. Bd. 32. H. 1. 2018 S. 30-37
Buhl, Roland; Criee, Carl-Peter; Kardos, Peter et al.
Dual bronchodilation vs triple therapy in the "real-life" COPD DACCORD studyINTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Bd. 13. 2018 S. 2557-2568
Andreas, Stefan; Bothner, Ulrich; Trampisch, Matthias et al.
Effect of long-acting beta(2)-agonists olodaterol and formoterol on heart rate and blood pressure in chronic obstructive pulmonary disease patientsPULMONARY PHARMACOLOGY & THERAPEUTICS. Bd. 52. 2018 S. 1-6
Stratmann, Jan A.; Michels, Sebastian; Hornetz, Sofia et al.
Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancerJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 144. H. 12. 2018 S. 2457-2463
Toelle, D.; Prax, F.; Schwanz, T. et al.
Epidemiology, risk factors, and clinical outcome of catheter-related blood stream infections in a German tertiary referral cancer centerONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 207-207
Pieper, Natalia; Zaremba, Anne; Leonardelli, Sonia et al.
Evolution of melanoma cross-resistance to CD8(+) T cells and MAPK inhibition in the course of BRAFi treatmentONCOIMMUNOLOGY. Bd. 7. H. 8. 2018